Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 148-reexam: Non-Final Action Mailed on 12-21-2007 meaning

Dec 21, 2007 09:58AM

Any connection between the timing of the USPTO's action and the judge's signing of the orders dismissing the case? Seems more than just coincidence to me! These patents are likely to emerge from PTO consideration stronger than before.


Dec 21, 2007 10:08AM

Dec 21, 2007 10:18AM

Dec 21, 2007 10:25AM
Share
New Message
Please login to post a reply